Genitourinary syndrome of menopause (GSM) is a cluster of vaginal, vulvar, and urinary symptoms caused by falling estrogen during and after menopause. Low estrogen thins and dries these tissues, leading to vaginal dryness, burning, painful intercourse, urinary urgency, and recurrent UTIs. GSM is progressive but treatable with hormone therapy, localized estrogen, and regenerative options.
Understanding Genitourinary Syndrome of Menopause
Answer: Genitourinary syndrome of menopause (GSM) is a cluster of vaginal, vulvar, and urinary symptoms caused by falling estrogen during and after menopause. As estrogen drops, the tissues lining the vagina and urinary tract grow thinner, drier, and less elastic, a process once called vaginal atrophy.
GSM symptoms tend to be progressive, so the underlying tissue changes worsen over time without treatment. The Cleveland Clinic notes that GSM affects a large share of postmenopausal women, yet many never raise it because they assume nothing can be done. Many routine visits address it with topical estrogen cream alone, which provides partial local relief. A more complete approach evaluates the full hormonal picture and pairs systemic hormone restoration for whole-body benefit with localized therapies for targeted tissue healing. You can find an overview of these tissue changes from the Cleveland Clinic.
What causes genitourinary syndrome of menopause?
Answer: GSM is caused mainly by a drop in estrogen, which the vaginal and urinary tissues depend on for thickness, moisture, elasticity, and a healthy pH. When estrogen falls, those tissues atrophy and become irritated and infection-prone.
The most common trigger is natural menopause, but the same estrogen loss occurs faster after surgical removal of the ovaries or after chemotherapy, pelvic radiation, and certain hormonal cancer therapies. Because the genitourinary system is highly estrogen-sensitive, it is often one of the first areas to show change. The North American Menopause Society describes GSM as driven by estrogen deficiency in the genital and urinary tissues.
What are the symptoms of GSM?
Answer: The hallmark symptoms are vaginal dryness, burning or itching, decreased lubrication, and painful intercourse, alongside urinary symptoms such as urgency, frequency, painful urination, and recurrent urinary tract infections.
These symptoms often appear together because the vagina, vulva, and lower urinary tract share the same estrogen-dependent tissue. Some people also notice light bleeding after intercourse or ongoing vulvar irritation. Unlike a passing dryness, GSM symptoms persist and tend to intensify, which is why they are best evaluated rather than endured.
How is GSM diagnosed?
Answer: GSM is usually diagnosed from your symptom history and a focused pelvic exam, sometimes supported by hormone bloodwork and tests to rule out infection or other causes of urinary symptoms.
During the exam, a clinician looks for the thinning, dryness, and loss of elasticity that point to estrogen deficiency. Vaginal pH may be checked, since GSM shifts the environment toward a higher pH. Lab work helps confirm where you are in the menopausal transition and ensures urinary symptoms are not driven by an active infection before treatment begins.
What are the treatment options for GSM?
Answer: Treatment ranges from localized vaginal estrogen and systemic hormone replacement therapy to regenerative options that rebuild tissue health, often combined for the best result.
The Mayo Clinic notes that low-dose vaginal estrogen is a first-line treatment for genitourinary symptoms, and systemic hormones add whole-body benefits when broader menopausal symptoms are present. The table below compares the main paths, all of which can be tailored to your labs, history, and goals.
| Treatment | How it works | Often best for |
|---|---|---|
| Hormone replacement therapy | Restores systemic estrogen so vaginal and urinary tissues regain thickness and moisture | GSM alongside hot flashes, sleep, and mood changes |
| Menopause treatment | A comprehensive program addressing the full menopausal transition | Anyone wanting full-spectrum care, not just genitourinary relief |
| O-Shot | PRP-based therapy that stimulates tissue repair and blood flow | Patients seeking regenerative support beyond hormones alone |
| Vaginal rejuvenation | Rebuilds tissue health at the cellular level for localized restoration | Targeted relief of dryness, irritation, and laxity |
Because GSM is hormonally driven, the most durable relief usually comes from addressing the estrogen deficit directly rather than relying on lubricants alone.
Is GSM reversible, and what is the outlook?
Answer: GSM is highly treatable, and restoring estrogen to the vaginal and urinary tissues can rebuild thickness, moisture, and elasticity so the tissue functions more normally again. Because the cause is ongoing estrogen loss, relief is maintained with continued care.
Most patients notice meaningful improvement in dryness, comfort, and urinary symptoms within weeks to a few months of starting treatment. The outlook is best when GSM is treated early, before the atrophy becomes advanced, and when the plan is monitored and adjusted over time rather than set once and forgotten.
How does GSM connect to menopause and hormones?
Answer: GSM is one of the most direct consequences of the estrogen decline that defines menopause, and it frequently overlaps with hot flashes, night sweats, sleep disruption, and mood changes that share the same hormonal root.
Because of that shared driver, GSM is often best treated as part of a broader hormonal plan rather than in isolation. Care at AgeRejuvenation is led by Chief Medical Director Dr. Dawn Ericsson, MD, a board-certified OB/GYN, with a team experienced in bioidentical hormone therapy and regenerative care. Treatment is dosed from comprehensive labs and adjusted with follow-up testing, so the plan fits your body rather than a default protocol.
When should you see a provider about GSM?
Answer: Seek evaluation as soon as dryness, burning, painful intercourse, or urinary symptoms begin to affect daily comfort, intimacy, or quality of life. Earlier care is generally easier and more effective than waiting for symptoms to become severe.
If you have a history of cancer or other conditions that complicate hormone use, evaluation is still worthwhile, since non-hormonal and localized options exist and care can be coordinated within your oncology team's guidelines. You can book an appointment for a confidential evaluation to map out the right plan for your stage and symptoms.
Common symptoms
Symptoms evaluated at AgeRejuvenation include:
How we treat genitourinary syndrome of menopause
Care plans are personalized to the root cause. Treatments include:
- Menopause treatment: For patients whose GSM is part of a broader menopausal transition, our comprehensive menopause program addresses the full spectrum, including vasomotor symptoms, mood, sleep, and cognitive function alongside genitourinary changes.
- Hormone replacement therapy: Restoring systemic estrogen through bioidentical hormone replacement helps vaginal and urinary tissues regain natural thickness, moisture, and elasticity, addressing GSM within the broader hormonal picture of mood, sleep, and cardiovascular health.
- O-Shot: The O-Shot uses PRP-based therapy to stimulate tissue repair and improve blood flow in vaginal and urethral tissues, supporting comfort and function beyond what hormones alone can achieve.
- Vaginal rejuvenation: Vaginal rejuvenation rebuilds tissue health at the cellular level to relieve dryness, irritation, and laxity, complementing hormone therapy for targeted, localized restoration.
